The medical technology industry is highly competitive and continues to evolve, with success measured by the development of innovative products and the value brought to stakeholders. The company is committed to developing new technologies and providing innovative patient care, which underscores the importance of mobilizing and deploying IT-based resources in combination with leveraging the value of other resources and capabilities. In 2019, the company invested 17.3% of its net sales in research and development, reflecting a focus on enhancing operational efficiency and aligning business strategies with technological advancements. The acquisition of CAS Medical Systems, Inc. is indicative of the company's strategy to enhance its technology portfolio and improve its capabilities in noninvasive monitoring, which is essential for supporting business needs and enhancing patient outcomes. The integration of advanced monitoring platforms, such as Hemosphere, demonstrates the company's commitment to operational flexibility and innovation in critical care, which is vital for maintaining competitive advantage in the market. The company’s financial performance is influenced by its ability to optimize resource allocation and manage operational processes effectively, which are critical components of its IT capability. The strategic decisions regarding the transcatheter aortic valve portfolio, including the discontinuation of the Centera program, reflect the company's focus on aligning its resources with market demands and operational goals. The emphasis on generating robust clinical, economic, and quality of life evidence is aligned with the need for effective information management capabilities that provide timely and accurate data to users, enhancing decision-making speed and supporting strategic resource allocation. The company’s efforts to defend its intellectual property and settle patent disputes are part of a broader strategy to safeguard its innovations and maintain its competitive positioning. The financial activities, including capital expenditures and investments in technology infrastructure, are aimed at enhancing the company's operational capabilities and ensuring compliance with evolving regulatory contexts. The management's focus on leveraging IT resources to support business processes and improve organizational effectiveness is essential for achieving performance gains and maintaining market agility. The ongoing evaluation of investment choices and the strategic alignment of technology capabilities with business objectives are critical for navigating the challenges posed by environmental factors and market dynamics. The company's approach to managing its technology deployment and enhancing its information systems capability reflects a commitment to continuous improvement and organizational transformation, which are vital for sustaining long-term business performance and resilience in a rapidly changing industry landscape.